Actively Recruiting
Study of an Implantable Microdevice to Test Drug Effects in Patients 10 Years and Older With Metastatic or Recurrent Sarcoma Undergoing Surgery
Led by M.D. Anderson Cancer Center · Updated on 2026-08-11
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and feasibility of implanting and removing a small drug delivery microdevice in patients with metastatic or recurrent sarcomas who are scheduled for surgery. This early phase I trial aims to find out which of the 10 different drugs delivered in tiny doses by the microdevice affect tumor tissue locally within the tumor. The study also seeks to predict drug responses and identify biomarkers related to treatment sensitivity and resistance. Participants receive up to three microdevices implanted percutaneously into their tumor tissue up to two days before their standard surgery. The microdevice slowly delivers small doses of drugs including doxorubicin hydrochloride, ifosfamide, vincristine, irinotecan, temozolomide, pazopanib, everolimus, polyethylene glycol, ganitumab, and temsirolimus. The devices are removed during the surgery two days later. This process is monitored for safety and technical success. During the study, participants are assessed for adverse events related to the device placement and removal, and their tumor tissue is examined to measure the effects of each drug delivered locally. Researchers collect data for up to one year to evaluate drug efficacy and the microdevices ability to predict systemic treatment responses. The study involves biopsy confirmation, consent, performance status evaluation, and standard surgical care, with a total participation timeline including implantation, surgery, and follow-up assessments.
CONDITIONS
Brief Title
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Research Team
J
Joseph A Ludwig, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here